1. Ureaplasma urealyticum Causes Hyperammonemia in an Experimental Immunocompromised Murine Model
- Author
-
Darci R. Block, Robin Patel, Kerryl E. Greenwood-Quaintance, Xiaohui Wang, Melissa J. Karau, Jayawant N. Mandrekar, and Scott A. Cunningham
- Subjects
0301 basic medicine ,Male ,Physiology ,medicine.medical_treatment ,lcsh:Medicine ,Artificial Gene Amplification and Extension ,medicine.disease_cause ,urologic and male genital diseases ,Pathology and Laboratory Medicine ,Polymerase Chain Reaction ,Mice ,0302 clinical medicine ,Prednisone ,Medicine and Health Sciences ,Hyperammonemia ,030212 general & internal medicine ,Respiratory System Procedures ,lcsh:Science ,Mice, Inbred C3H ,Multidisciplinary ,Immunosuppression ,Animal Models ,Hematology ,3. Good health ,Bacterial Pathogens ,Body Fluids ,Chemistry ,Blood ,Medical Microbiology ,Physical Sciences ,Pathogens ,Anatomy ,Ureaplasma urealyticum ,Immunosuppressive Agents ,medicine.drug ,Research Article ,Lung Transplantation ,Immunology ,Mouse Models ,Surgical and Invasive Medical Procedures ,Biology ,Real-Time Polymerase Chain Reaction ,Research and Analysis Methods ,Microbiology ,Immune Suppression ,Mycophenolic acid ,Tacrolimus ,Blood Plasma ,03 medical and health sciences ,Immunocompromised Host ,Model Organisms ,Signs and Symptoms ,Ammonia ,Diagnostic Medicine ,medicine ,Lung transplantation ,Animals ,Molecular Biology Techniques ,Microbial Pathogens ,Molecular Biology ,Transplantation ,Ureaplasma infection ,Ureaplasma Infections ,lcsh:R ,Chemical Compounds ,Biology and Life Sciences ,Organ Transplantation ,Mycophenolic Acid ,medicine.disease ,Disease Models, Animal ,030104 developmental biology ,lcsh:Q - Abstract
Hyperammonemia syndrome is an often fatal complication of lung transplantation which has been recently associated with Ureaplasma infection. It has not been definitely established that Ureaplasma species can cause hyperammonemia. We established a novel immunocompromised murine model of Ureaplasma urealyticum infection and used it to confirm that U. urealyticum can cause hyperammonemia. Male C3H mice were pharmacologically immunosuppressed with mycophenolate mofetil, tacrolimus and oral prednisone for seven days, and then challenged intratracheally (IT) and/or intraperitoneally (IP) with 107 CFU U. urealyticum over six days, while continuing immunosuppression. Spent U. urealyticum-free U9 broth was used as a negative control, with uninfected immunocompetent mice, uninfected immunosuppressed mice, and infected immunocompetent mice serving as additional controls. Plasma ammonia concentrations were compared using Wilcoxon ranks sum tests. Plasma ammonia concentrations of immunosuppressed mice challenged IT/IP with spent U9 broth (n = 14) (range 155-330 μmol/L) were similar to those of normal mice (n = 5), uninfected immunosuppressed mice (n = 5), and U. urealyticum IT/IP challenged immunocompetent mice (n = 5) [range 99-340 μmol/L, p = 0.60]. However, immunosuppressed mice challenged with U. urealyticum IT/IP (n = 20) or IP (n = 15) had higher plasma ammonia concentrations (range 225-945 μmol/L and 276-687 μmol/L, respectively) than those challenged IT/IP with spent U9 broth (p
- Published
- 2016